Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor

A 45-year old man was diagnosed with desmoplastic small round cell tumor (DSRCT) with involvement of the peritoneum and pelvis. Disease progression was observed despite systemic chemotherapy. Six months after diagnosis, he developed severe hypoglycemia presented with seizures. He received intravenou...

Full description

Saved in:
Bibliographic Details
Main Authors: Williams Fernandes Barra, Gilberto Castro, Ana Oliveira Hoff, Sheila A. C. Siqueira, Paulo M. Hoff
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2010/684045
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553725367943168
author Williams Fernandes Barra
Gilberto Castro
Ana Oliveira Hoff
Sheila A. C. Siqueira
Paulo M. Hoff
author_facet Williams Fernandes Barra
Gilberto Castro
Ana Oliveira Hoff
Sheila A. C. Siqueira
Paulo M. Hoff
author_sort Williams Fernandes Barra
collection DOAJ
description A 45-year old man was diagnosed with desmoplastic small round cell tumor (DSRCT) with involvement of the peritoneum and pelvis. Disease progression was observed despite systemic chemotherapy. Six months after diagnosis, he developed severe hypoglycemia presented with seizures. He received intravenous glucose infusion and hydrocortisone with poor glycemic control, but with seizures resolution. The investigation excluded insulinoma, adrenal, liver and GH deficiencies. Laboratory showed slight rise of IGF-II and significant increase of the ratio IGF-II : IGF-I, which is pathognomonic of non-islet cell tumor hypoglycemia (NICTH). He received the diagnoses of NICTH related to IGF-II inappropriate production by DSRCT. Despite the attempt to control tumor mass and hypoglycemia, the patient died 9 months after diagnosis. NICTH related to inappropriate IGF-II secretion should be investigated in all cancer patients with refractory hypoglycemia whom insulinoma and other metabolic abnormalities were excluded from.
format Article
id doaj-art-06c517561281435a9ee32f05300cdeae
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-06c517561281435a9ee32f05300cdeae2025-02-03T05:53:21ZengWileyCase Reports in Medicine1687-96271687-96352010-01-01201010.1155/2010/684045684045Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell TumorWilliams Fernandes Barra0Gilberto Castro1Ana Oliveira Hoff2Sheila A. C. Siqueira3Paulo M. Hoff4Departamento de Oncologia Clínica, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, BrazilDepartamento de Oncologia Clínica, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, BrazilEndocrinology, Grupo Fleury, São Paulo, BrazilDepartamento de Oncologia Clínica, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, BrazilDepartamento de Oncologia Clínica, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, BrazilA 45-year old man was diagnosed with desmoplastic small round cell tumor (DSRCT) with involvement of the peritoneum and pelvis. Disease progression was observed despite systemic chemotherapy. Six months after diagnosis, he developed severe hypoglycemia presented with seizures. He received intravenous glucose infusion and hydrocortisone with poor glycemic control, but with seizures resolution. The investigation excluded insulinoma, adrenal, liver and GH deficiencies. Laboratory showed slight rise of IGF-II and significant increase of the ratio IGF-II : IGF-I, which is pathognomonic of non-islet cell tumor hypoglycemia (NICTH). He received the diagnoses of NICTH related to IGF-II inappropriate production by DSRCT. Despite the attempt to control tumor mass and hypoglycemia, the patient died 9 months after diagnosis. NICTH related to inappropriate IGF-II secretion should be investigated in all cancer patients with refractory hypoglycemia whom insulinoma and other metabolic abnormalities were excluded from.http://dx.doi.org/10.1155/2010/684045
spellingShingle Williams Fernandes Barra
Gilberto Castro
Ana Oliveira Hoff
Sheila A. C. Siqueira
Paulo M. Hoff
Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor
Case Reports in Medicine
title Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor
title_full Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor
title_fullStr Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor
title_full_unstemmed Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor
title_short Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor
title_sort symptomatic hypoglycemia related to inappropriately high igf ii serum levels in a patient with desmoplastic small round cell tumor
url http://dx.doi.org/10.1155/2010/684045
work_keys_str_mv AT williamsfernandesbarra symptomatichypoglycemiarelatedtoinappropriatelyhighigfiiserumlevelsinapatientwithdesmoplasticsmallroundcelltumor
AT gilbertocastro symptomatichypoglycemiarelatedtoinappropriatelyhighigfiiserumlevelsinapatientwithdesmoplasticsmallroundcelltumor
AT anaoliveirahoff symptomatichypoglycemiarelatedtoinappropriatelyhighigfiiserumlevelsinapatientwithdesmoplasticsmallroundcelltumor
AT sheilaacsiqueira symptomatichypoglycemiarelatedtoinappropriatelyhighigfiiserumlevelsinapatientwithdesmoplasticsmallroundcelltumor
AT paulomhoff symptomatichypoglycemiarelatedtoinappropriatelyhighigfiiserumlevelsinapatientwithdesmoplasticsmallroundcelltumor